1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Drs. Bruce Rosengard and Sanuj Ravindran Join The Medicines Company New … – MarketWatch (press release)

July 19, 2012Transplant Rejectionadmin

Drs. Bruce Rosengard and Sanuj Ravindran Join The Medicines Company New ...
MarketWatch (press release)
Dr. Rosengard started his career at The University of Pennsylvania, where he performed the first combined heart-lung transplant at that institution, described a novel cellular mechanism responsible for the triggering of transplant rejection, and ...

and more »

Post navigation

← Vitamin E can cut down risk of liver cancer: study – Business Standard Drs. Bruce Rosengard and Sanuj Ravindran Join The Medicines Company New … – Marketwire (press release) →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos